These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31993661)

  • 21. Narcolepsy in the older adult: epidemiology, diagnosis and management.
    Chakravorty SS; Rye DB
    Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study.
    Dauvilliers Y; Arnulf I; Szakacs Z; Leu-Semenescu S; Lecomte I; Scart-Gres C; Lecomte JM; Schwartz JC;
    Sleep; 2019 Oct; 42(11):. PubMed ID: 31529094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 10-Year Longitudinal Observational Study Of Cataplexy In A Cohort Of Narcolepsy Type 1 Patients.
    Almeneessier AS; Alballa NS; Alsalman BH; Aleissi S; Olaish AH; BaHammam AS
    Nat Sci Sleep; 2019; 11():231-239. PubMed ID: 31695532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Mobile App for Longterm Monitoring of Narcolepsy Symptoms: Design, Development, and Evaluation.
    Quaedackers L; De Wit J; Pillen S; Van Gilst M; Batalas N; Lammers GJ; Markopoulos P; Overeem S
    JMIR Mhealth Uhealth; 2020 Jan; 8(1):e14939. PubMed ID: 31909723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ullanlinna Narcolepsy Scale in diagnosis of narcolepsy.
    Sarkanen T; Alakuijala A; Partinen M
    Sleep; 2019 Mar; 42(3):. PubMed ID: 30476331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disrupted nighttime sleep and sleep instability in narcolepsy.
    Maski K; Mignot E; Plazzi G; Dauvilliers Y
    J Clin Sleep Med; 2022 Jan; 18(1):289-304. PubMed ID: 34463249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of depressive symptoms in narcoleptic patients with and without cataplexy.
    Jara CO; Popp R; Zulley J; Hajak G; Geisler P
    J Nerv Ment Dis; 2011 May; 199(5):329-34. PubMed ID: 21543952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-Reported Measures of Narcolepsy: The Need for Better Assessment.
    Kallweit U; Schmidt M; Bassetti CL
    J Clin Sleep Med; 2017 May; 13(5):737-744. PubMed ID: 28162143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
    Baumann CR; Khatami R; Werth E; Bassetti CL
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study.
    Mansukhani MP; Kotagal S
    Sleep Med; 2012 Jun; 13(6):606-10. PubMed ID: 22445591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence to wakefulness promoting medication in patients with narcolepsy.
    Pérez-Carbonell L; Lyons E; Gnoni V; Higgins S; Otaiku AI; Leschziner GD; Drakatos P; d'Ancona G; Kent BD
    Sleep Med; 2020 Jun; 70():50-54. PubMed ID: 32197224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bupropion is effective in depression in narcolepsy.
    Goksan B; Mercan S; Karamustafalioglu O
    Int J Psychiatry Clin Pract; 2005; 9(4):289-91. PubMed ID: 24930928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing sleepiness and cataplexy in children and adolescents with narcolepsy: a review of current patient-reported measures.
    Benmedjahed K; Wang YG; Lambert J; Evans C; Hwang S; Black J; Johns MW
    Sleep Med; 2017 Apr; 32():143-149. PubMed ID: 28366326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is memory impaired in narcolepsy type 1?
    Medrano-Martínez P; Gómez-Sacristan Á; Peraita-Adrados R
    J Sleep Res; 2022 Oct; 31(5):e13593. PubMed ID: 35388527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulant and anticataplectic effects of reboxetine in patients with narcolepsy: a pilot study.
    Larrosa O; de la Llave Y; Bario S; Granizo JJ; Garcia-Borreguero D
    Sleep; 2001 May; 24(3):282-5. PubMed ID: 11322710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subjective nocturnal symptoms have different associations with depressive symptoms and anxiety than with daytime sleepiness in patients with obstructive sleep apnea.
    Lee SA; Kim HJ; Lee Y
    Sleep Med; 2020 May; 69():58-64. PubMed ID: 32045855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life and procrastination in post-H1N1 narcolepsy, sporadic narcolepsy and idiopathic hypersomnia, a Swedish cross-sectional study.
    Wasling HB; Bornstein A; Wasling P
    Sleep Med; 2020 Dec; 76():104-112. PubMed ID: 33152582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defining disrupted nighttime sleep and assessing its diagnostic utility for pediatric narcolepsy type 1.
    Maski K; Pizza F; Liu S; Steinhart E; Little E; Colclasure A; Diniz Behn C; Vandi S; Antelmi E; Weller E; Scammell TE; Plazzi G
    Sleep; 2020 Oct; 43(10):. PubMed ID: 32253429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The therapeutic potential of opioids in narcolepsy type 1: A systematic literature review and questionnaire study.
    Gool JK; van Heese EM; Schinkelshoek MS; Remmerswaal A; Lammers GJ; van Dijk KD; Fronczek R
    Sleep Med; 2023 Sep; 109():118-127. PubMed ID: 37437491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in the DTI-ALPS index and choroid plexus volume are associated with clinical symptoms in participants with narcolepsy type 1.
    Hu P; Yuan Y; Zou Y; Xiong R; Dai J; Zhao X; Xie L; Tang X
    Sleep Med; 2024 Dec; 124():471-478. PubMed ID: 39427503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.